Search
Celldex Therapeutics Inc
CLDXAdd to Watchlist
31.650USD
-0.530-1.65%
Close 10-02 16:00（ET）
2.48BMarket Cap
LossP/E TTM
Celldex Therapeutics Inc (CLDX) Stock Price Target & Forecast
Analyst Rating
Based on 15 analysts giving stock ratings to Celldex Therapeutics Inc in the past month.
Buy
5 Strong Buy
9 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
63.071USD+99.28%
CLDX Analyst Recommendation Trends
In the current month, CLDX has received 9 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CLDX average Analyst price target in the last month is 63.071.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
5
5
5
5
5
5
4
4
9
9
10
10
10
9
9
9
1
1
1
1
1
1
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
15
15
16
16
16
16
16
16
CLDX Analyst Rating for Peer Comparison
Updated: Oct 4, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
IQVIA Holdings Inc
IQV
7
12
6
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Biontech SE
BNTX
4
12
6
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, CLDX EPS is projected to reach -1.021 in FY2026Q3, following reported EPS of -0.944 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.01
-1.14
-1.06
-1.02
-1.02
Actual
-1.22
-1.18
-0.94
--
--
Surprise
-21.25%
-3.79%
+10.63%
--
--
FAQs
What is Celldex Therapeutics Inc's expected revenue for the next quarter?
Celldex Therapeutics Inc's expected revenue is 707.14K.
What is Celldex Therapeutics Inc's price target?
Analysts forecast that Celldex Therapeutics Inc's price target is USD 63.07, with the highest forecast at USD 100.00 and the lowest forecast at USD 28.00.
How have Celldex Therapeutics IncCLDX's recent earnings per share performed?
The market expectation was USD -0.94, while Celldex Therapeutics IncCLDX's earnings per share (EPS) for the previous quarter was USD -1.18. EPS for the next quarter is expected at USD -1.02.
What is the analyst rating for Celldex Therapeutics Inc?
Based on the ratings of Celldex Therapeutics Inc's stock from 15 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.